Below are the financial statements of TG Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 179.89a | 92.93a |
| Short-term investment securities | 131.11a | 124.58a |
| Accounts receivable, net | 129.19a | 51.09a |
| Inventories | 110.46a | 39.82a |
| Other current assets | 15.72a | 9.52a |
| Total current assets | 566.36a | 317.94a |
| Restricted cash | 1.3a | 1.29a |
| Long-term investment securities | 0.81a | 0a |
| Right of use assets | 7.15a | 8.05a |
| Other noncurrent assets | 2.07a | 2.31a |
| Total assets | 577.69a | 329.59a |
| Liabilities and stockholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable and accrued expenses | 58.3a | 38.47a |
| Other current liabilities | 4.63a | 1.48a |
| Lease liability - current portion | 1.16a | 1.45a |
| Deferred revenue - current portion | 11.41a | 0.15a |
| Accrued compensation | 15.19a | 12.17a |
| Total current liabilities | 90.68a | 53.72a |
| Deferred revenue, non-current portion | 12.09a | 6.02a |
| Loan payable | 244.43a | 100.12a |
| Lease liability - non-current | 8.13a | 9.23a |
| Total liabilities | 355.33a | 169.09a |
| Stockholders’ equity | — | — |
| Common stock | 0.16a | 0.15a |
| Additional paid-in capital | 1,760.4a | 1,713.16a |
| Treasury stock, at cost | -8.99a | -0.23a |
| Accumulated deficit | -1,529.19a | -1,552.58a |
| Total stockholders’ equity | 222.36a | 160.5a |
| Total liabilities and stockholders’ equity | 577.69a | 329.59a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.